News

Once dismissed as “junk” DNA, ancient viruses embedded in the human genome play a key role in early human development, ...
Q2 2025 Earnings Call Transcript August 7, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.7 ...
The FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with early, active cerebral adrenoleukodystrophy (CALD), to reflect new safety ...
Gene Mack, CEO of Gain Therapeutics, outlines the company’s strategic approach to advancing GT-02287 through potential collaborations and financing options as they await critical Parkinson’s disease ...
Neuroblastoma can be a particularly insidious cancer. In about half of all cases, tumors regress, even without therapy. In ...